Innoviva Inc - ESG Rating & Company Profile powered by AI
The Disclosure score includes seventeen United Nations SDGs including: 'Clean Water & Sanitation', 'Decent Work & Economic Growth' and 'Life on Land'. The webpage is a zero-cost ESG report covering Innoviva Inc. The article includes a questions and answers section for Innoviva Inc.
Innoviva Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 4.0, social score of 4.8 and governance score of 3.2.
4.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
| 989 | Tricida Inc | 4.1 | High |
| 1004 | Innoviva Inc | 4.0 | High |
| 1004 | Can B Corp | 4.0 | High |
| 1004 | CLS Holdings USA Inc | 4.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Innoviva Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Innoviva Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Innoviva Inc report the average age of the workforce?
Sign up for free to unlockDoes Innoviva Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Innoviva Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Innoviva Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Innoviva Inc offer flexible work?
Sign up for free to unlockDoes Innoviva Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Innoviva Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Innoviva Inc conduct supply chain audits?
Sign up for free to unlockDoes Innoviva Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Innoviva Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Innoviva Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Innoviva Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Innoviva Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Innoviva Inc disclose water use targets?
Sign up for free to unlockDoes Innoviva Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Innoviva Inc have a product recall in the last two years?
Sign up for free to unlockDoes Innoviva Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Innoviva Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Innoviva Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Innoviva Inc disclose parental leave metrics?
Sign up for free to unlockDoes Innoviva Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Innoviva Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Innoviva Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Innoviva Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Innoviva Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Innoviva Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Innoviva Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Innoviva Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Innoviva Inc disclose its waste policy?
Sign up for free to unlockDoes Innoviva Inc report according to TCFD requirements?
Sign up for free to unlockDoes Innoviva Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Innoviva Inc disclose energy use targets?
Sign up for free to unlockDoes Innoviva Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Innoviva Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Innoviva Inc
These potential risks are based on the size, segment and geographies of the company.
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.